Researchers are excited about the medication , a groundbreaking dual compound showing significant results in initial trials for weight reduction . It acts by targeting two pathways : GLP-1 and GIP, https://monicaxqts291756.bloggazza.com/39536479/this-new-prospect-for-body-management